Skip to main content

Advertisement

SpringerLink
Log in

An overview of current biomaterials in aesthetic soft tissue augmentation

  • Original Paper
  • Published:
European Journal of Plastic Surgery Aims and scope Submit manuscript

Abstract

Today an increasing number of patients seek aesthetic improvement through minimally invasive procedures, and interest in soft tissue augmentation and filling agents is rising steadily. However, a thorough understanding of these substances, their indications and contraindications, as well as a profound knowledge of different implantation techniques is essential to provide an aesthetically pleasing result for the patient. This presentation gives an overview of the current injectable biomaterials, their major indications, advantages and disadvantages, with focus on collagen, hyaluronic acid, poly-l-lactide, and autologous fat grafting.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  1. Neuber F (1893) Fettransplantation. Chir Kongr Verhandl Dsch Gesellch Chir 22:66

    Google Scholar 

  2. Klein AW, Elson ML (2000) The history of substances for soft tissue augmentation. Dermatol Surg 26:1096–1105

    Article  PubMed  CAS  Google Scholar 

  3. Baumann L (2002) Soft tissue augmentation. In: Baumann L (ed) Cosmetic dermatology principles and practice. McGraw-Hill, New York, pp 155–172

    Google Scholar 

  4. Clark DP, Hanke CW, Swanson NA (1989) Dermal implants: safety of products injected for soft tissue augmentation. J Am Acad Dermatol 21:992–998

    Article  PubMed  CAS  Google Scholar 

  5. Klein AW (1992) Injectable collagen. In: Moschells SL, Hurley HJ (eds) Dermatology. W.B. Saunders Co., Philadelphia, pp 2455–2461

    Google Scholar 

  6. Hanke CW, Coleman WP III (1997) Dermal filler substances. In: Asken S, Alt TH, Hanke CW, Coleman WP III (eds) Cosmetic surgery of the skin. Mosby, St. Louis, pp 217–230

    Google Scholar 

  7. Hanke CW, Higley HR, Jolivette DM, Swanson NA, Stegman SJ (1991) Abscess formation and local necrosis after treatment with Zyderm or Zyplast collagen implant. J Am Acad Dermatol 25:319–326

    Article  PubMed  CAS  Google Scholar 

  8. Elson ML (1989) The role of skin testing in the use of collagen injectable materials. J Dermatol Surg Oncol 15:301–303

    PubMed  CAS  Google Scholar 

  9. Stegman SJ, Chu S, Armstrong RC (1988) Adverse reactions to bovine collagen implant: clinical and histologic features. J Dermatol Surg Oncol 14:39–48

    Google Scholar 

  10. Castrow FF 2nd, Krull EA (1983) Injectable collagen implant–update. J Am Acad Dermatol 9:889–893

    Article  PubMed  Google Scholar 

  11. Siegle RJ, McCoy JP Jr, Schade W, Swanson NA (1984) Intradermal implantation of bovine collagen. Humoral immune responses associated with clinical reactions. Arch Dermatol 120:183–187

    Article  PubMed  CAS  Google Scholar 

  12. Klein AW, Rish DC (1984) Injectable collagen update. J Dermatol Surg Oncol 10:519–522

    PubMed  CAS  Google Scholar 

  13. Klein AW (1989) In favor of double testing. J Dermatol Surg Oncol 15:263

    PubMed  CAS  Google Scholar 

  14. Baumann LS, Kerdel F (1999) The treatment of bovine collagen allergy with cyclosporin. Dermatol Surg 25:247–249

    Article  PubMed  CAS  Google Scholar 

  15. Moody BR, Sengelmann RD (2001) Topical tacrolimus in the treatment of bovine collagen hypersensitivity. Dermatol Surg 27:789–791

    Article  PubMed  CAS  Google Scholar 

  16. Cukier J, Beauchamp RA, Spindler JS, Spindler S, Lorenzo C, Trentham DE (1993) Association between bovine collagen dermal implants and a dermatomyositis or a polymyositis-like syndrome. Ann Intern Med 118:920–928

    PubMed  CAS  Google Scholar 

  17. Hanke CW, Thomas JA, Lee WT, Jolivette DM, Rosenberg MJ (1996) Risk assessment of polymyositis/dermatomyositis after treatment with injectable bovine collagen implants. J Am Acad Dermatol 34:450–454

    Article  PubMed  CAS  Google Scholar 

  18. Rosenberg MJ, Reichlin M (1994) Is there an association between injectable collagen and polymyositis/dermatomyositis? Arthritis Rheum 37:747–753

    Article  PubMed  CAS  Google Scholar 

  19. Elson ML (1993) Injectable collagen and autoimmune disease. J Dermatol Surg Oncol 19:165–168 discussion 170

    PubMed  CAS  Google Scholar 

  20. Lemperle G, Gauthier-Hazan N, Lemperle M (1998) PMMA-microspheres (Artecoll) for long-lasting correction of wrinkles: refinements and statistical results. Aesthetic Plast Surg 22:356–365

    Article  PubMed  CAS  Google Scholar 

  21. Cohen SR, Holmes RE (2004) Artecoll: a long-lasting injectable wrinkle filler material: report of a controlled, randomized, multicenter clinical trial of 251 subjects. Plast Reconstr Surg 114:964–976 discussion 977–979

    Article  PubMed  Google Scholar 

  22. Bauman L (2004) CosmoDerm/CosmoPlast (human bioengineered collagen) for the aging face. Facial Plast Surg 20:125–128

    Article  PubMed  Google Scholar 

  23. Perret S, Eble JA, Siljander PR et al (2003) Prolyl hydroxylation of collagen type I is required for efficient binding to integrin alpha 1 beta 1 and platelet glycoprotein VI but not to alpha 2 beta 1. J Biol Chem 278:29873–29879

    Article  PubMed  CAS  Google Scholar 

  24. Okada S, Hagan JB, Kato M et al (1998) Lidocaine and its analogues inhibit IL-5-mediated survival and activation of human eosinophils. J Immunol 160:4010–4017

    PubMed  CAS  Google Scholar 

  25. Menon NG et al (2003) Revascularization of human acellular dermis in full-thickness abdominal wall reconstruction in the rabbit model. Ann Plast Surg 50:523–527

    Article  PubMed  Google Scholar 

  26. Silverman RP et al (2004) Ventral hernia repair using allogenic acellular dermal matrix in a swine model. Hernia 8:336–342

    Article  PubMed  CAS  Google Scholar 

  27. Lattari V, Jones LM, Varcelotti JR, Latenser BA, Sherman HF, Barrette RR (1997) The use of a permanent dermal allograft in full-thickness burns of the hand and foot: a report of three cases. J Burn Care Rehabil 18:147–155

    Article  PubMed  CAS  Google Scholar 

  28. Sclafani AP, Romo T, Jacono AA III (2002) Rejuvenation of the aging lip with an injectable acellular dermal graft (Cymetra). Arch Facial Plast Surg 4:252–257

    Article  PubMed  Google Scholar 

  29. Hanke CW, Coleman WP III (1997) Dermal filler substances. In: Asken S, Alt TH, Hanke CW, Coleman WP III (eds) Cosmetic surgery of the skin. Mosby, St. Louis, pp 217–230

    Google Scholar 

  30. Sutherland I (1988) Novel and established applications of microbial polysaccharides. Trends Biotechnol 16:41–46

    Article  Google Scholar 

  31. Fink RM, Lengfelder E (1987) Hyaluronic acid degradation by ascorbic acid and influence of iron. Free Rad Res Comm 3:85–92

    Article  CAS  Google Scholar 

  32. Monheit GD (2004) “Hylaform: a new hyaluronic acid filler” in soft tissue augmentation. Facial Plast Surg 20:153–157

    Article  PubMed  Google Scholar 

  33. Olenius M (1988) The first clinical study using a new biodegradable implant for treatment of lips, wrinkles, and folds. Aesthetic Plast Surg 22:97–101

    Article  Google Scholar 

  34. Duranti F, Salti G, Bovani B, Calandra M, Rosati ML (1998) Injectable hyaluronic acid gel for soft tissue augmentation: a clinical and histological study. Dermatol Surg 24:1317–1325

    Article  PubMed  CAS  Google Scholar 

  35. Narins RS, Brandt F, Leyden J, Lorenc ZP, Rubin M, Smith S (2003) A randomized, double-blind, multicenter comparison of the efficacy and tolerability of Restylane versus Zyplast for the correction of nasolabial folds. Dermatol Surg 29:588–595

    Article  PubMed  Google Scholar 

  36. Lupton JR, Alster TS (2000) Cutaneous hypersensitivity reaction to injectable hyaluronic acid gel. Dermatol Surg 26:135–137

    Article  PubMed  CAS  Google Scholar 

  37. Lowe NJ, Maxwell CA, Patanaik R (2005) Adverse reactions to dermal fillers: review. Dermatol Surg 31:1616–1625

    PubMed  CAS  Google Scholar 

  38. Micheels P (2002) Human anti-hyaluronic acid antibodies: is it possible? Dermatol Surg 28:359–360

    Google Scholar 

  39. Friedman PM, Mafung EA, Kauvar AN, Gerronemus RG (2002) Safety data non-injectable non-animal stabilized hyaluronic acid gel for soft tissue augmentation. Dermatol Surg 28:491–494

    Article  PubMed  Google Scholar 

  40. Athanasiou KA, Niederauer GG, Agrawal CM, Landsman AS (1995) Applications of biodegradable lactides and glycolides in podiatry. Clin Podiatr Med Surg 12:475–495

    PubMed  CAS  Google Scholar 

  41. Tonnard PL, Verpaele AM (2004) The MACS-Lift. Short-scan rhyfidectomy. Quality Medical Publishing, St. Louis

    Google Scholar 

  42. Brady JM, Cutright DE, Miller RA, Barristone GC (1973) Resorption rate, route, route of elimination, and ultrastructure of the implant site of polylactic acid in the abdominal wall of the rat. J Biomed Mater Res 7:155–166

    Article  PubMed  CAS  Google Scholar 

  43. Moyle GJ, Lysakova L, Brown S et al (2004) A randomized open-label study of immediate versus delayed polylactic acid injections for the cosmetic management of facial lipoatrophy in persons with HIV infection. HIV Med 5:82–87

    Article  PubMed  CAS  Google Scholar 

  44. Humble G, Mest D (2004) Soft tissue augmentation using sculptra. Facial Plast Surg 20:157–163

    Article  PubMed  Google Scholar 

  45. Lemperle G, Morhenn VB, Pestonjamasp V, Gallo RL (2004) Migration studies and histology of injectable microspheres of different sizes in mice. Plast Reconstr Surg 113:1380–1390

    Article  PubMed  Google Scholar 

  46. Bergsma JE, Rozema FR, Bos RR, Boering G, de Bruijn WC, Pennings AJ (1995) In vivo degradation and biocompatibility study of in vitro pre-degraded as-polymerized polyactide particles. Biomaterials 16:267–274

    Article  PubMed  CAS  Google Scholar 

  47. Christensen L, Breiting V, Janssen M, Vuust J, Hogdall E (2005) Adverse reactions to injectable soft tissue permanent fillers. Aesthetic Plast Surg 29:34–48

    Article  PubMed  Google Scholar 

  48. Burgess CM, Quiroga RM (2005) Assessment of the safety and efficacy of poly-L-lactic acid for the treatment of HIV-associated facial lipoatrophy. J Am Acad Dermatol 52:233–239

    Article  PubMed  Google Scholar 

  49. Lemperle G, Morhenn V, Charrier U (2003) Human histology and persistence of various injectable filler substances for soft tissue augmentation. Aesthetic Plast Surg 27:354–366 discussion 367

    Article  PubMed  Google Scholar 

  50. Gogolewski S, Jovanovic M, Perren SM, Dillon JG, Hughes MK (1993) Tissue response and in vivo degradation of selected polyhydroxyacids: polylactides (PLA), poly (3-hydroxybutyrate) (PHB), and poly (3-hydroxybutyrate-co-3-hydroxyvalerate) (PHB/VA). J Biomed Mater Res 27:1135–1148

    Article  PubMed  CAS  Google Scholar 

  51. Moe KS, Weisman RA (2001) Resorbable fixation in facial plastic and head and neck reconstructive surgery: an initial report on polylactic acid implants. Laryngoscope 111:1697–1701

    Article  PubMed  CAS  Google Scholar 

  52. Woerle B, Hanke CW, Sattler G (2004) Poly-L-lactic acid: a temporary filler for soft tissue augmentation. J Drugs Dermatol 3:385–389

    PubMed  Google Scholar 

  53. Lombardi T, Samson J, Plantier F, Husson C, Kuffer R (2004) Orofacial granulomas after injection of cosmetic fillers. Histopathologic and clinical study of 11 cases. J Oral Pathol Med 33:115–120

    Article  PubMed  CAS  Google Scholar 

  54. Jones D (2005) HIV lipoatrophy: causes and treatment options. Dermatol Surg 31:1519–1529

    Article  PubMed  CAS  Google Scholar 

  55. Spenlehauer G, Vert M, Benoit JP, Boddaert A (1989) In vitro and in vivo degradation of poly (D,L lactide/glycolide) type microspheres made by solvent evaporation method. Biomaterials 10:557–563

    Article  PubMed  CAS  Google Scholar 

  56. Lichtenstein KA, Ward DJ, Moorman AC et al (2001) Clinical assessment of HIV-associated lipodystrophy in an ambulatory population. AIDS 15:1389–1398

    Article  PubMed  CAS  Google Scholar 

  57. James J, Carruthers A, Carruthers J (2002) HIV-associated facial lipoatrophy. Dermatol Surg 28:979–986

    Article  PubMed  Google Scholar 

  58. Collins E, Wagner C, Walmsley S (2000) Psychosocial impact of the lipodystrophy syndrome in HIV infection. AIDS Read 10:546–550

    PubMed  CAS  Google Scholar 

  59. Amard P, Saint Marc T, Katz P (2000) The effects of polylactic acid (NewFill) as therapy for lipoatrophy of the face. Abstract p. 94. Second International Workshop on Adverse Drug Reactions and Lipodystrophy in HIV, Toronto, Canada, September 13–15

  60. Lafaurie M, Dolivo M, Boulu D et al (2003) Treatment of facial lipoatrophy with injections of polylactic acid in HIV-infected patients. Poster presentaion: 10th Conference on Retroviruses and Opportunistic Infections, Boston, MA, February 10–14

  61. Valantin MA, Aubron-Olivier C, Ghosn J et al (2003) Polylactic acid implants (NewFill) to correct facial lipoatrophy in HIV-infected patients: results of the open-label study VEGA. AIDS 17:2471–2477

    Article  PubMed  CAS  Google Scholar 

  62. Mest D, Humble G (2004) Safety and efficiency of poly-L-lactic acid (Sculptra) injections for patients with HIV-associated facial lipoatrophy. Antiviral Ther 9:L36

    Google Scholar 

  63. Laglenne S (2000) Un nouveau produit de comblement des rides, entirerment resorbable. Dermatologie 54:30–33

    Google Scholar 

  64. Bauer U (2004) Improvement of facial aesthetics at 40 months with injectable poly-L-lactic acid (PLLA). Poster 164. 17th Congress of the International Society of Aesthetic Plastic Surgery in Houston, Texas, August

  65. Lexer E (1910) Freie Fettransplantation. Dtsch Med Wochenschr 36:640

    Google Scholar 

  66. Illouz Y (1986) The fat cell “graft” a new technique to fill depressions. Plast Reconstr Surg 78:122

    Article  PubMed  CAS  Google Scholar 

  67. Fournier P (1989) Facial recontouring with fat grafting. Dermatol Clin 8:523

    Google Scholar 

  68. Klein JA (1990) Tumescent technique for regional anaesthesia permits lidocaine doses of 35 mg/kg for liposuction. J Dermatol Surg Oncol 16:248–263

    PubMed  CAS  Google Scholar 

  69. Coleman WP III, Lawrence N, Sherman RN et al (1993) Autologous collagen: lipocytic dermal augmentation–a histopathologic study. J Dermatol Surg Oncol 19:1032

    PubMed  Google Scholar 

  70. Coleman SR (1997) Facial recontouring with lipostructure. Clin Plastic Surg 24:347–367

    CAS  Google Scholar 

  71. Peer LA (1950) Loss of weight and volume in human fat grafts with postulation of "cell survival theory". Plast Reconstr Surg 5:217

    Article  Google Scholar 

  72. Billings E Jr, May JW Jr (1989) Historical review and present status of free fat graft autotransplantation in plastic and reconstructive surgery. Plast Reconstr Surg 83(2):368–381

    Article  PubMed  Google Scholar 

  73. Ersek RA (1991) Transplantation of purified autologous fat: a 3-year follow-up is disappointing. Plast Reconstr Surg 87(2):219–227 discussion 228

    Article  PubMed  CAS  Google Scholar 

  74. Sommer B, Sattler G (2000) Current concepts of fat graft survival: histology of aspirated adipose tissue and review of the literature. Dermatol Surg 26:1159–1166

    Article  PubMed  CAS  Google Scholar 

  75. Van R, Roncari D (2004) Complete differentiation of adipocyte precursors: a culture system for studying the cellular nature of adipose tissue. Cell Tissue Res 181:197–203

    Google Scholar 

  76. Van RL, Roncari DA (1978) Complete differentiation of adipocyte precursors. A culture system for studying the cellular nature of adipose tissue. Cell Tissue Res 195(2):317–329

    PubMed  CAS  Google Scholar 

  77. Billings E Jr, May JW Jr (1989) Historical review and present status of free fat graft autotransplantation in plastic and reconstructive surgery. Plast Reconstr Surg 83(2):368–381

    Article  PubMed  Google Scholar 

  78. Koellensperger E et al (2006) Human serum from platelet-poor plasma for the culture of primary human preadipocytes. Stem Cells 24:1218–1225

    Article  PubMed  CAS  Google Scholar 

  79. Smahel J (1989) Experimental implantation of adipose tissue fragments. Br J Plast Surg 42(2):207–211

    Article  PubMed  CAS  Google Scholar 

  80. Dillerud E (1990) Abdominoplasty combined with suction lipoplasty: a study of complications, revisions, and risk factors in 487 cases. Ann Plast Surg 25:333–338

    Article  PubMed  CAS  Google Scholar 

  81. Brüner S, Deb R, Germann G (2003) Konservative Faltenbehandlung in der Hand des Plastischen Chirurgen. Chirurg 74:815–820

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department for Hand, Plastic and Reconstructive Surgery, Intensive Burn Care Unit, BG-Trauma Centre Ludwigshafen, Ludwig Guttmann Str. 13, 67071, Ludwigshafen, Germany

    H. Ryssel, G. Germann & E. Koellensperger

  2. Department for Plastic and Hand Surgery, The University of Heidelberg, Heidelberg, Germany

    H. Ryssel, G. Germann & E. Koellensperger

Authors
  1. H. Ryssel
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. G. Germann
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. E. Koellensperger
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to H. Ryssel.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ryssel, H., Germann, G. & Koellensperger, E. An overview of current biomaterials in aesthetic soft tissue augmentation. Eur J Plast Surg 35, 121–133 (2012). https://doi.org/10.1007/s00238-008-0251-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00238-008-0251-1

Keywords

Search

Navigation